![]() Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | ![]() Dermavant Sciences Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology. | ![]() Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
| |
Founding Date | Founding Date 2003 | Founding Date 2016 | Founding Date 2006 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Utrecht, NL HQ Cambridge, US | Locations Long Beach, US HQ Basel, CH Durham, US Morrisville, US New York, US Phoenix, US | Locations San Diego, US HQ San Diego, US |
Employees | Employees 260 | Employees 2228% decrease | Employees 31019% decrease |
Valuation ($) | Valuation ($) 3.6 b | Valuation ($) N/A | Valuation ($) 1.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) $36.1m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $62.8m (FY, 2022) |
Net income | Net income ($215.3m) (FY, 2024) | Net income ($255.3m) (FY, 2019) | Net income ($577.8m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 149.3m | Total funding raised $ 200m | Total funding raised $ 42.6m |

Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology.
View company
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
View company